Inventor profile of:

Ping Li

City:

Basking Ridge, New Jersey

Country:

United States

Published Applications:

17

Last publication date:

2019-02-21

Top Assignees for applications by Ping Li

The entities that hold a legal rights for patent applications filed by inventor Li Ping:

Recent patent applications by Li Ping

Ping Li from Basking Ridge, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-02-21
US20190054086A1
Human necessities

Pharmaceutical formulations of (S)-methyl(1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate

#2 | 2017-07-20
US20170202837A1
Human necessities

Method of treating colorectal cancer by administration of pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)pheny1)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl) carbamate

#3 | 2016-09-29
US20160279129A1
Human necessities

Method of treating melanoma by administration of pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate

#4 | 2016-04-14
US20160101179A1
Human necessities

COMPOUND FORMULATIONS OF 2-AMINO-1, 3-PROPANEDIOL COMPOUNDS

#5 | 2015-11-12
US20150320749A1
Human necessities

Immediate release 4-methyl-3-4[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol-1-YL)-3-(trifluoromethyl)phenyl] benzamide formulation

#6 | 2014-10-16
US20140309250A1
Human necessities

Pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate

#7 | 2014-04-03
US20140094522A1
Human necessities

COMPOUND FORMULATIONS OF 2-AMINO-1, 3-PROPANEDIOL COMPOUNDS

#8 | 2013-09-19
US20130245061A1
Chemistry; metallurgy

PHARMACEUTICAL COMPOSITIONS

#9 | 2012-07-12
US20120177733A1
Human necessities

SOLID DOSAGE FORMS OF VALSARTAN AND AMLODIPINE AND METHOD OF MAKING THE SAME

#10 | 2012-06-28
US20120164218A1
Human necessities

Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same

#11 | 2010-12-02
US20100303906A1
Human necessities

SOLID DOSAGE FORMS OF VALSARTAN AND AMLODIPINE AND METHOD OF MAKING SAME

#12 | 2010-02-11
US20100035949A1
Human necessities

MICROEMULSION DOSAGE FORMS OF VALSARTAN AND METHODS OF MAKING THE SAME

#13 | 2010-01-07
US20100003321A1
Human necessities

SOLID DOSAGE FORMS OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE AND METHOD OF MAKING THE SAME

#14 | 2009-09-03
US20090218714A1
Performing operations; transporting

APPARATUS

#15 | 2008-07-17
US20080171086A1
Human necessities

Solid Dosage Forms of Valsartan and Amlo Dipine and Method of Making the Same

#16 | 2008-04-24
US20080096972A1
Human necessities

COMPOUND FORMULATIONS OF 2-AMINO-1, 3-PROPANEDIOL COMPOUNDS

#17 | 2008-03-13
US20080064760A1
Human necessities

Spontaneously Dispersible Pharmaceutical Composition

InventorID:

445853 ⎘